A detailed history of Bruce G. Allen Investments, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 49 shares of TXG stock, worth $651. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49
Previous 163 69.94%
Holding current value
$651
Previous $3.17 Million 65.11%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$15.71 - $23.49 $1,790 - $2,677
-114 Reduced 69.94%
49 $1.11 Million
Q2 2024

Jul 12, 2024

BUY
$19.45 - $37.37 $2,664 - $5,119
137 Added 526.92%
163 $3.17 Million
Q4 2023

Jan 10, 2024

BUY
$34.32 - $57.55 $892 - $1,496
26 New
26 $1.46 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.26B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Bruce G. Allen Investments, LLC Portfolio

Follow Bruce G. Allen Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce G. Allen Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruce G. Allen Investments, LLC with notifications on news.